Integrated psychiatric/medical care in a chronic hepatitis C clinic: Affect on antiviral treatment evaluation and outcomes

American Journal of Gastroenterology

Volumn 101, Issue 10, 2006, Pages 2254-2262

  Knott, Astrid ^a   Dieperink, Eric ^a,b   Willenbring, Mark L ^a,b   Heit, Sara ^a,b   Durfee, Janet M ^a,c   Wingert, Mary ^a   Johnson, James R ^c   Thuras, Paul ^b   Ho, Samuel B ^a,c,d,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MENTAL DISEASE; PRIORITY JOURNAL; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; ANTIVIRAL AGENTS; BEHAVIOR THERAPY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT COMPLIANCE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33749162949     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00731.x     Document Type: Article

References (32)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
2. Mendenhall CL, Moritz T, Rouster S, et al. Epidemiology of hepatitis C among veterans with alcoholic liver disease. Am J Gastroenterol 1993;88:1022-6.
3. Rosenberg SD, Swanson JW, Wolford GL, et al. The five-site health and risk study of blood-borne infections among persons with severe mental illness. Psychiatr Serv 2003;54:827-35.
4. Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005;41:88-96.
5. Edlin BR. Five million Americans infected with the hepatitis C virus: A corrected estimate [abstract]. Hepatology 2005;42:213A.
6. Yawn BP, Wollan P, Gazzuola L, et al. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. J Fam Pract 2002;51:135-40.
7. Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J Gen Intern Med 2005;20:754-8.
8. Rocca LG, Yawn BP, Wollan P, et al. Management of patients with hepatitis C in a community population: Diagnosis, discussions, and decisions to treat. Ann Fam Med 2004;2:116-24.
9. Falck-Ytter Y, Kale H, Mullen KD, et al. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002;136:288-92.
10. El-Serag HB, Kunik M, Richardson P, et al. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002;123:476-82.
11. Yovtcheva SP, Rifai MA, Moles JK, et al. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001;42:411-5.
12. Lehman CL, Cheung RC. Depression, anxiety, posttraumatic stress, and alcohol-related problems among veterans with chronic hepatitis C. Am J Gastroenterol 2002;97:2640-6.
13. Cawthorne CH, Rudat KR, Burton MS, et al. Limited success of HCV antiviral therapy in United States veterans. Am J Gastroenterol 2002;97:149-55.
14. Muir AJ, Provenzale D. A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. J Clin Gastroenterol 2002;34:268-71.
15. Rowan PJ, Tabasi S, Abdul-Latif M, et al. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C. J Clin Gastroenterol 2004;38:530-4.
16. Fireman M, Indest DW, Blackwell A, et al. Addressing trimorbidity (hepatitis C, psychiatric disorders, and substance use): The importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis 2005;40:286-91.
17. Nguyen HA, Miller AI, Dieperink E, et al. Spectrum of disease in U.S. veteran patients with hepatitis C. Am J Gastroenterol 2002;97:1813-20.
18. Bini EJ, Bräu N, Currie S, et al. Prospective multicenter study of eligibility for antiviral therapy among 4084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005;100:1772-9.
19. National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 - June 10-12, 2002. Hepatology 2002;36:S3-20.
20. Willenbring ML. Integrating care for patients with infectious, psychiatric, and substance use disorders: Concepts and approaches. AIDS 2005;19:S227-37.
21. Weisner C, Mertens J, Parthasarathy S, et al. Integrating primary medical care with addiction treatment: A randomized controlled trial. JAMA 2001;286:1715-23.
22. Willenbring ML, Olson DH. A randomized trial of integrated outpatient treatment for medically ill alcoholic men. Arch Intern Med 1999;159:1946-52.
23. Lucas GM, Weidle PJ, Hader S, et al. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: A nonrandomized comparative study. Clin Infect Dis 2004;38:S409-13.
24. McCance-Katz EF, Gourevitch MN, Arnsten J, et al. Modified directly observed therapy (MDOT) for injection drug users with HIV disease. Am J Addict 2002;11:271-8.
25. Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158:1789-95.
26. Office of Quality and Performance, Veterans Health Administration, Department of Veterans Affairs. FY05 VHA Performance Measure: 15 b. Substance Use Disorder. 2004, Retrieved August 8, 2005, from http://www.oqp.med.va.gov/ general/uploads/FINAL%20FY05%20TM%20 substance use disorders%2010%2018%2004.doc
27. Prins A, Ouimette P, Kimerling R, et al. The primary care PTSD screen (PC-PTSD): Development and operating characteristics. Primary Care Psychiatry 2003;9:9-14.
28. Beck AT, Beamesderfer A. Assessment of depression: The depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151-69.
29. Whitlock EP, Polen MR, Green CA, et al. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140:557-68.
30. Wright TL, Yee H. Patients with chronic hepatitis C. VA treatment recommendations (Version 5.0). Fed Pract 2003;20:1-33.
31. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001;358:958-65.
32. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-82.